Literature DB >> 15175359

Evidence that hepatic lipase deficiency in humans is not associated with proatherogenic changes in HDL composition and metabolism.

Isabelle L Ruel1, Patrick Couture, Jeffrey S Cohn, Andre Bensadoun, Michel Marcil, Benoit Lamarche.   

Abstract

The aim of the present study was to characterize the composition and metabolism of HDL in subjects with complete hepatic lipase (HL) deficiency. Analyses were carried out in three complete and three partial HL-deficient subjects as well as in eight normotriglyceridemic (NTG) and two hypertriglyceridemic controls. Complete HL deficiency was associated with hypertriglyceridemia and with a 3.5-fold increase in HDL-triglyceride (TG) levels. The in vivo kinetics of apolipoprotein A-I (apoA-I) and apoA-II (d < 1.25 g/l) were studied in the fasted state using a primed-constant infusion of l-(5,5,5-D3)leucine for 12 h. Complete HL deficiency was associated with a reduced fractional catabolic rate of apoA-I in the HL-deficient female proband (-47%) and in her two brothers (-21%) compared with gender- and TG-matched controls. Total plasma and HDL from complete HL-deficient patients were able to mediate normal cholesterol efflux from human skin fibroblasts labeled with [3H]cholesterol. Complete HL deficiency was also associated with normal levels of prebeta-migrating apoA-I-containing HDL separated by two-dimensional gel electrophoresis and with an accumulation of large HDL particles compared with NTG controls. These results suggest that HL activity is important for adequate HDL metabolism, although its presence may not be necessary for normal HDL-mediated reverse cholesterol transport. Copyright 2004 American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15175359     DOI: 10.1194/jlr.M400090-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  14 in total

1.  Secretion of triacylglycerol-poor VLDL particles from McA-RH7777 cells expressing human hepatic lipase.

Authors:  Michelle Bamji-Mirza; Meenakshi Sundaram; Shumei Zhong; Erik F Yao; Robin J Parks; Zemin Yao
Journal:  J Lipid Res       Date:  2010-12-27       Impact factor: 5.922

Review 2.  Studying apolipoprotein turnover with stable isotope tracers: correct analysis is by modeling enrichments.

Authors:  Rajasekhar Ramakrishnan
Journal:  J Lipid Res       Date:  2006-09-01       Impact factor: 5.922

Review 3.  Treatment of dyslipidemia in children and adolescents.

Authors:  Kathryn Wood Holmes; Peter Oscar Kwiterovich
Journal:  Curr Cardiol Rep       Date:  2005-11       Impact factor: 2.931

Review 4.  Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport.

Authors:  Robert S Rosenson; H Bryan Brewer; W Sean Davidson; Zahi A Fayad; Valentin Fuster; James Goldstein; Marc Hellerstein; Xian-Cheng Jiang; Michael C Phillips; Daniel J Rader; Alan T Remaley; George H Rothblat; Alan R Tall; Laurent Yvan-Charvet
Journal:  Circulation       Date:  2012-04-17       Impact factor: 29.690

5.  Positive association of the hepatic lipase gene polymorphism c.514C > T with estrogen replacement therapy response.

Authors:  Alvaro Pulchinelli; Ana Maria Massad Costa; Cristina V de Carvalho; Naiara Correa Nogueira de Souza; Mauro A Haidar; Adagmar Andriolo; Ismael D C Guerreiro da Silva
Journal:  Lipids Health Dis       Date:  2011-11-02       Impact factor: 3.876

Review 6.  Familial dyslipidaemias: an overview of genetics, pathophysiology and management.

Authors:  Sahar B Hachem; Arshag D Mooradian
Journal:  Drugs       Date:  2006       Impact factor: 9.546

7.  High-density lipoprotein subpopulation profiles in lipoprotein lipase and hepatic lipase deficiency.

Authors:  Mariko Tani; Katalin V Horvath; Benoit Lamarche; Patrick Couture; John R Burnett; Ernst J Schaefer; Bela F Asztalos
Journal:  Atherosclerosis       Date:  2016-08-20       Impact factor: 5.162

8.  Reactive Oxygen Species, SUMOylation, and Endothelial Inflammation.

Authors:  Nhat-Tu Le; James P Corsetti; Janet L Dehoff-Sparks; Charles E Sparks; Keigi Fujiwara; Jun-Ichi Abe
Journal:  Int J Inflam       Date:  2012-09-06

9.  Apolipoprotein A-II influences apolipoprotein E-linked cardiovascular disease risk in women with high levels of HDL cholesterol and C-reactive protein.

Authors:  James P Corsetti; Stephan J L Bakker; Charles E Sparks; Robin P F Dullaart
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240

Review 10.  Role of hepatic lipase and endothelial lipase in high-density lipoprotein-mediated reverse cholesterol transport.

Authors:  Wijtske Annema; Uwe J F Tietge
Journal:  Curr Atheroscler Rep       Date:  2011-06       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.